Expression of CTLA-4 Molecule in Peripheral Blood T Lymphocytes from Patients with Systemic Lupus Erythematosus
Authors:
- Chrong-Reen WangCWChrong-Reen Wang
- Huan-Yao LeiHLHuan-Yao Lei
- 1 November 1998
- journal article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 18 (6) , 392-398
Abstract
CTLA-4 is a cell surface molecule expressed on activated T cells that is suggested to deliver a negative signal for T cell activation. Since CTLA-4 might be a negative regulator of autoimmune...Keywords
This publication has 31 references indexed in Scilit:
- CTLA4 Alanine-17 Confers Genetic Susceptibility to Graves’ Disease and to Type 1 Diabetes Mellitus1The Journal of Clinical Endocrinology & Metabolism, 1997
- CTLA-4 ligation blocks CD28-dependent T cell activation.Journal of Experimental Medicine, 1996
- Defective antigen‐presenting cell function in patients with systemic lupus erythematosus: Role of the B7‐1 (CD80) costimulatory moleculeArthritis & Rheumatism, 1996
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Science, 1995
- CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.Journal of Experimental Medicine, 1995
- Expression of functional B7 and CTLA4 on rheumatoid synovial T cells.The Journal of Immunology, 1994
- CD28-B7 interactions in T-cell activationCurrent Opinion in Immunology, 1994
- Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.Journal of Experimental Medicine, 1992
- CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal locationThe Journal of Immunology, 1991
- Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen.Journal of Clinical Investigation, 1979